Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population | Zendy

Maikel V. W. van der Velden | Zendy; Richard Fritz | Zendy; Martin Bauer | Zendy; Daniel Portsmouth | Zendy; M. Keith Howard | Zendy; Thomas R. Kreil | Zendy; Thomas Dvorak | Zendy; S. Fritsch | Zendy; Timo Vesikari | Zendy; Javier DíezDomingo | Zendy; Peter Richmond | Zendy; B. W. Lee | Zendy; Otfried Kistner | Zendy; Hartmut J. Ehrlich | Zendy; Perry Barrett | Zendy; Gerald Aichinger | Zendy

Open Access

Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population

Author(s) -

Maikel V. W. van der Velden,

Richard Fritz,

Martin Bauer,

Daniel Portsmouth,

M. Keith Howard,

Thomas R. Kreil,

Thomas Dvorak,

S. Fritsch,

Timo Vesikari,

Javier DíezDomingo,

Peter Richmond,

B. W. Lee,

Otfried Kistner,

Hartmut J. Ehrlich,

Perry Barrett,

Gerald Aichinger

Publication year - 2013

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1093/infdis/jit498

Subject(s) - immunogenicity , virology , vaccination , medicine , influenza vaccine , population , influenza a virus subtype h5n1 , immunization , neuraminidase , live attenuated influenza vaccine , booster dose , herd immunity , virus , pandemic , antibody titer , immunology , antibody , titer , environmental health , infectious disease (medical specialty) , covid-19 , disease

Children are highly vulnerable to infection with novel influenza viruses. It is essential to develop candidate pandemic influenza vaccines that are safe and effective in the pediatric population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research